Stockreport

Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha]

Fate Therapeutics, Inc.  (FATE) 
Last fate therapeutics, inc. earnings: 3/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.fatetherapeutics.com/investor-relations
PDF Fate Therapeutics, Inc. (NASDAQ: FATE Company Participants Scott Wolchko - President and Chief Executive Officer Daniel Shoemaker - Chief Scientific Officer Wayne Chu - [Read more]